“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
Chronic lymphocytic leukemia (CLL) displays an extremely variable clinical behaviour. Accurate prognostication and prediction of response to treatment is important in an era of effective first-line regimens and novel molecules for high risk patients. Because a plethora of prognostic biomarkers were...
Main Authors: | Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2016-10-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/2481 |
Similar Items
-
Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia
by: Celso Arrais Rodrigues, et al. -
Biological Prognostic Markers in Chronic Lymphocytic Leukemia
by: Vladimíra Vroblová, et al.
Published: (2009-01-01) -
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
by: Xiaoya Yun, et al.
Published: (2020-09-01) -
Leucemia: fatores prognósticos e genética Leukemia: genetics and prognostic factors
by: Nelson Hamerschlak
Published: (2008-08-01) -
The Impact of Chlorambucil and Valproic Acid on Cell Viability, Apoptosis and Expression of <i>p21</i>, <i>HDM2</i>, <i>BCL2</i> and <i>MCL1</i> Genes in Chronic Lymphocytic Leukemia
by: Katarzyna Lipska, et al.
Published: (2021-05-01)